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ollagen plays a critical role in hemostasis by promoting
adhesion and activation of platelets at sites of vessel
injury. In the present model of platelet–collagen inter-
action, adhesion is mediated via the inside-out regulation
of integrin 
 
 
 
2
 
 
 
1
 
 and activation through the glycoprotein VI
(GPVI)–Fc receptor (FcR) 
 
 
 
-chain complex. The present
study extends this model by demonstrating that engagement
of 
 
 
 
2
 
 
 
1
 
 by an integrin-speciﬁc sequence from within collagen
 
or by collagen itself generates tyrosine kinase–based intra-
cellular signals that lead to formation of ﬁlopodia and
lamellipodia in the absence of the GPVI–FcR 
 
 
 
-chain
complex. The same events do not occur in platelet suspen-
sions. 
 
 
 
2
 
 
 
1
 
 activation of adherent platelets stimulates tyrosine
C
 
phosphorylation of many of the proteins in the GPVI–FcR
 
 
 
-chain cascade, including Src, Syk, SLP-76, and PLC
 
 
 
2 as
well as plasma membrane calcium ATPase and focal adhesion
kinase. 
 
 
 
2
 
 
 
1
 
-mediated spreading is dramatically inhibited
in the presence of the Src kinase inhibitor PP2 and in
PLC
 
 
 
2-deﬁcient platelets. Spreading is abolished by chelation
of intracellular Ca
 
2
 
 
 
. Demonstration that adhesion of platelets
to collagen via 
 
 
 
2
 
 
 
1
 
 generates intracellular signals provides
a new insight into the mechanisms that control thrombus
formation and may explain the unstable nature of 
 
 
 
1
 
-deﬁcient
thrombi and why loss of the GPVI–FcR 
 
 
 
-chain complex
has a relatively minor effect on bleeding.
 
Introduction
 
Platelets play a critical role in the events that lead to thrombus
formation and cessation of bleeding at sites of damage to the
vasculature. They also play a major role in thrombotic diseases
such as stroke and myocardial infarction. Platelet activation
is an integrated process involving subendothelial matrix
proteins and soluble agonists that support adhesion and activa-
tion. Collagen is unique among these stimuli in that it not
only plays a key role in platelet tethering and adhesion, but
it is also a powerful agonist that is capable of producing full
activation. A full understanding of the role of collagen in
hemostasis is essential toward an understanding of cardio-
vascular disease and new forms of therapeutic intervention.
Collagen interacts with platelets through direct and indirect
mechanisms. At the medium and high shear rates found in
arterioles and damaged vascular beds, von Willebrand factor
(vWf)* bridges newly exposed collagen fibers to the GPIb–
IX–V complex on the platelet surface. This interaction is
facilitated by a fast on-rate of association between vWf and
GPIb
 
 
 
 and is essential for the initial tethering of platelets
by collagen at medium to high rates of shear (Savage et al.,
1996, 1998). The interaction is opposed by a rapid off-rate
of dissociation such that platelets translocate (or roll) for
several minutes on vWf in the absence of other proteins before
forming stable adhesion through activated 
 
 
 
IIb
 
 
 
3
 
 (Savage et
al., 1996). The situation in vivo however is very different,
as a number of extracellular matrix proteins work in tandem
with vWf to promote stable adhesion, notably collagen.
Platelets interact with collagen through two major surface
receptors, the integrin 
 
 
 
2
 
 
 
1
 
 and GPVI, as well as with a
number of minor receptors of uncertain significance (for review
see Watson and Gibbins, 1998). For many years, the inter-
action of collagen with 
 
 
 
2
 
 
 
1
 
 was thought to be essential for
adhesion, whereas the role of GPVI was to mediate activation.
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The understanding of these events has changed consider-
ably, however, after a number of recent observations using
function blocking antibodies and genetically modified mice.
In particular, the observation that platelets show dramati-
cally impaired adhesion to collagen under static and shear
conditions in the absence of functional GPVI demonstrates
a critical role for the glycoprotein in platelet adhesion
(Nieswandt et al., 2001a). This can be explained by the loss
of inside-out signals from GPVI, which promote 
 
 
 
2
 
 
 
1
 
 acti-
vation and enable it to bind to collagen (Jung and Moroi,
1998, 2000). More recently, GPVI has been shown to play a
critical role in the interaction of platelets with vWf in vitro
(Goto et al
 
.,
 
 2002) and with a denuded endothelial carotid
artery in vivo (Massberg et al
 
.,
 
 2003), demonstrating that it
is required at the very initial stage of thrombus formation.
These observations highlight a central role for GPVI–Fc
receptor (FcR) 
 
 
 
-chain in the interaction of platelets with
collagen but do not explain why mice deficient in the glyco-
protein show only a minor increase in bleeding times
(Nieswandt et al., 2001b). It therefore seems prudent to sug-
gest that other matrix proteins play a role in promoting
thrombus formation and can thereby compensate for the ab-
sence of GPVI. In this context, it is pertinent to consider the
role of 
 
 
 
2
 
 
 
1
 
 in greater detail, because not only is it a major
receptor for collagen but it can also be activated by G pro-
tein–coupled receptor agonists independent of GPVI.
The role of 
 
 
 
2
 
 
 
1
 
 in platelet–collagen interactions is criti-
cally dependent on experimental conditions. A universal
finding of 
 
 
 
2
 
 
 
1
 
 blockade is a delay in response to collagen,
although in many cases the final extent of activation is not
altered. However, under certain experimental conditions,
blockade of the integrin can lead to an abolition of adhesion
and activation. This is illustrated by the contrasting reports
of Chen et al. (2002) and Holtkötter et al. (2002) on the ad-
hesion of 
 
 
 
2
 
-deficient murine platelets to collagen under
flow. Chen et al. (2002) reported a dramatic inhibition of
adhesion to collagen, using washed platelets in a low Ca
 
2
 
 
 
-
containing buffer, conditions that favor the interaction with
the integrin. In contrast, Holtkötter et al. (2002) reported a
negligible effect of 
 
 
 
2
 
 ablation on adhesion, using plasma
and a physiological concentration of Ca
 
2
 
 
 
. A similar obser-
vation has also been reported in 
 
 
 
1
 
-deficient murine plate-
lets in the presence of plasma (Nieswandt et al., 2001a). In a
recent follow-up to this study, however, the same group de-
scribed an increased tendency of the 
 
 
 
1
 
-deficient thrombi to
fragment at later times in the experiment compared with
those formed by wild-type platelets (Kuijpers et al., 2003).
Careful examination of these thrombi revealed that they
were more loosely packed than those found in control cells
(Kuijpers et al., 2003). This observation demonstrates an
unexpected role for 
 
 
 
2
 
 
 
1
 
 in the later stages of hemostasis
that is critical for thrombus stability, even though it has no
role in the initial events that underlie adhesion.
Suzuki-Inoue et al. (2001) have recently reported spreading
of human platelets on Fab fragments of an 
 
 
 
2
 
 
 
1
 
-activating an-
tibody, TS2/16. In light of this, we wondered whether the in-
creased embolization of the 
 
 
 
1
 
-deficient thrombi was caused
by a loss of integrin-mediated intracellular signals that medi-
ate remodeling of the cytoskeleton and thereby contribute to
thrombus stability. In the present study, we show that a col-
 
lagen peptide that binds exclusively to 
 
 
 
2
 
 
 
1
 
 generates tyrosine
kinase–based intracellular signals that underlie platelet spread-
ing. Importantly, a similar set of observations are seen with
collagen in murine platelets deficient in GPVI–FcR 
 
 
 
-chain.
Both sets of responses are inhibited by 
 
 
 
2
 
 
 
1
 
 blockade. Strik-
ingly, the intracellular signaling cascade used by 
 
 
 
2
 
 
 
1
 
 shares
many of the features of the GPVI signaling cascade, including
participation of Src kinases and PLC
 
 
 
2. The observation that
engagement of 
 
 
 
2
 
 
 
1
 
 can induce a similar set of signals to
GPVI provides a new insight into the role of 
 
 
 
2
 
 
 
1
 
 in platelet
activation by collagen and may explain the relatively minor ef-
fect of depletion of GPVI–FcR 
 
 
 
-chain on bleeding times
(Nieswandt et al., 2001b) and the increased tendency of 
 
 
 
1
 
-
deficient thrombi to embolize (Kuijpers et al., 2003).
 
Results
 
Spreading of human platelets 
on collagen-coated surfaces
 
Adhesion and spreading of washed human platelets on a col-
lagen-coated surface was investigated in the presence of
maximally effective concentrations of the cyclooxygenase in-
hibitor indomethacin, the P2Y
 
1
 
 and P2Y
 
12
 
 ADP receptor
antagonists A3P5P and AR-C67085, and the 
 
 
 
IIb
 
 
 
3
 
 antago-
nist lotrafiban. Confirmation that this cocktail of inhibitors
was fully effective was shown by the abolition of shape
change and 
 
 
 
IIb
 
 
 
3 
 
aggregation to a high concentration of
collagen (100 
 
 
 
g/ml) (unpublished data).
Platelets underwent time-dependent adhesion and forma-
tion of filopodia and lamellipodia on a collagen surface (Fig.
1, A and B). The majority of platelets had spread fully after
30 min, although a number showed intermediate changes in
morphology most likely because of a more recent contact
with the collagen surface. Because the changes in morphol-
ogy occurred in the presence of inhibitors, it is suggested
that adhesion and spreading are directly mediated through
collagen receptors. In contrast, very few platelets settled on a
BSA-coated surface and those that did, did not undergo a
change in morphology (Fig. 1 A).
The role of the integrin 
 
 
 
2
 
 
 
1
 
 in adhesion and spreading on
collagen was investigated using the 
 
 
 
2
 
 
 
1
 
-blocking mAb 6F1.
The number of platelets that formed stable adhesions on col-
lagen was reduced in the presence of 6F1 from 78.7 
 
 
 
 6.2 per
0.028 mm
 
2
 
 to 31.5 
 
 
 
 1.5 per 0.028 mm
 
2
 
 at 30 min (P 
 
 
 
0.01) (Fig. 1 A). In addition, the formation of filopodia and
lamellipodia was impaired (Fig. 1 A). These results demon-
strate a vital role for 
 
 
 
2
 
 
 
1
 
 in mediating adhesion and spreading
on collagen. In contrast, adhesion and formation of filopodia
and lamellipodia was readily seen in platelets exposed to a sur-
face coated with a similar concentration of the GPVI-specific
peptide CRP (unpublished data). This more marked response
is likely to reflect the 10-fold greater density of the GPVI-spe-
cific binding motif, GPO, in CRP in comparison to collagen.
 
GPVI–FcR 
 
 
 
-chain–deficient murine platelets spread 
on collagen in the presence of ADP
 
Spreading of mouse platelets on a collagen-coated surface
was investigated in the presence of the above cocktail of in-
hibitors. The platelets underwent time-dependent adhesionT
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and formation of filopodia and lamellipodia on the collagen
surface (Fig. 2 A). Murine platelets deficient in the GPVI–
FcR 
 
 -chain complex showed a marked reduction in adhe-
sion to collagen of  60% and underwent only limited
spreading (Fig. 2 B, 1 [i and ii]). The interaction of collagen
with  2 1 is increased by inside-out activation of the inte-
grin by stimuli such as ADP and PMA (Jung and Moroi,
1998, 2000). ADP (Fig. 2 B, 1 [iii]) or PMA (unpublished
data) restored adhesion and spreading of FcR  -chain–defi-
cient platelets, although this was ablated in the presence of
an  2 1-blocking antibody (Fig. 2 B, 1 [iv]) but not by an
isotype-matched control (unpublished data). These findings
demonstrate that  2 1 is able to support spreading on col-
lagen in the absence of GPVI and that either the integrin
and/or the stimulus used to promote inside-out signaling is
able to mediate spreading.
Platelets spread on the  2 1-specific triple helical 
peptide GFOGER
We are presently unable to study spreading of human plate-
lets on collagen in the absence of GPVI because of the lack
of a GPVI-blocking antibody or access to individuals who
are deficient in GPVI. To investigate the ability of  2 1 to
stimulate spreading in human platelets, we therefore used an
 2 1-specific, triple-helical peptide developed by Knight et
al. (1998, 2000). GFOGER peptide contains one copy of an
integrin  2 1 recognition motif, GFOGER, in a backbone
of repeat GPP sequences and is cross-linked by NH2- and
COOH-terminal cysteines. The GPP motif is inactive on
 2 1 and GPVI but is required to confer a helical conforma-
tion on the peptide (Morton et al., 1995).
Human and murine platelets adhere and undergo exten-
sive spreading on GFOGER-coated surfaces in the presence
of indomethacin, ADP receptor antagonists, and lotrafiban
(Fig. 3 A, 1 and 2, and B, 1). The formation of filopodia and
lamellipodia can be clearly seen (Fig. 3 A, 3). Adhesion of
human platelets to the GFOGER monolayer was ablated in
the presence of the  2 1-blocking antibody 6F1 (Fig. 3 A, 1
and 2), but not in the presence of an isotype-matched con-
trol or the anti-GPIb mAb 6D1 (Fig. 3 A, 4). The latter pro-
vides evidence of specificity in the action of mAb 6F1, espe-
cially bearing in mind that GPIb is present at an  10 times
greater level than the integrin. Adhesion of murine platelets
to GFOGER is inhibited by an  2 1-blocking antibody
(Fig. 3 B, 1 and 2) but not by an isotype-matched control
(unpublished data). A similar number of platelets also un-
dergo adhesion and spreading from wild-type, GPVI–FcR
 -chain–deficient, and  IIb-deficient mice, demonstrating
that adhesion is not dependent on GPVI or the integrin
 IIb 3 (Fig. 3 B). Consistent with this, GFOGER peptide
did not induce significant tyrosine phosphorylation of the
FcR  -chain in human platelets (Fig. 3 A, 5), as measured by
precipitation with a GST–Syk SH2 domain fusion protein
(Gibbins et al., 1996). Platelet adhesion to a monolayer
of CRP served as a positive control for these studies (Fig.
3 A, 5). These findings are consistent with reports that
GFOGER peptide is unable to bind GPVI (Knight et al.,
1998, 2000) and demonstrate that engagement of  2 1 by a
fibrillar collagen binding sequence mediates spreading. 
 2 1 mediates platelet spreading through 
a Src kinase–dependent pathway
We considered it likely that the intracellular signals driven by
 2 1 would be similar to those regulated by the platelet-spe-
Figure 1. Spreading of human platelets on collagen. (A) Washed 
human platelets (2   10
7/ml) were pretreated with 100  M EGTA, 
10  M indomethacin, 10  M lotrafiban, 1 mM A3P5P, and 1  M 
AR-C67085 (inhibitor cocktail) with or without 10  g/ml 6F1 and 
10  g/ml VI.3. IV.3 was used to prevent platelet activation by the Fc 
portion of 6F1. Platelets were seeded on coverslips coated with 1% 
fatty acid–free BSA or 50  g/ml collagen for the indicated times at 
30 C. After unbound platelets were removed, the platelets were fixed 
by 3% paraformaldehyde, stained by TRITC-labeled phalloidin for 
actin fibers, and photographed with fluorescent microscopy. (B) The 
number of adhered platelets per 0.028 mm
2. The graph illustrates 
the mean number of adhered platelets   SEM per 0.028 mm
2 from 
seven different images from three experiments. Photo images are 
representative of 5–10 different images from three experiments.T
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cific integrin  IIb 3.  IIb 3 mediates spreading through a Src
kinase–dependent pathway that lies upstream of the tyrosine
kinase Syk (Obergfell et al., 2002). Consistent with this, the
Src kinase inhibitor PP2 was observed to inhibit  2 1-medi-
ated spreading (P   0.01) but not adhesion of human plate-
lets on GFOGER (Fig. 4 A). PP3, which is an inactive ana-
logue of PP2, did not inhibit spreading on GFOGER (Fig. 4
A). PP2 also partially inhibited spreading but not adhesion of
FcR  -chain–deficient murine platelets on a collagen-coated
surface treated with ADP (Fig. 4 B), suggesting that the Src
kinase inhibitor does not interfere with the inside-out activa-
tion of  2 1 by the G protein receptor ligand. The struc-
turally distinct Src kinase inhibitor SU6656 (20  M) also
inhibited spreading but not adhesion of human and FcR
 -chain–deficient murine platelets on GFOGER (unpub-
lished data). These results demonstrate a key role for Src ki-
nases in  2 1-mediated spreading but not adhesion. 
GFOGER peptide stimulates tyrosine phosphorylation 
of focal adhesion kinase (FAK) and PLC 2
We investigated the ability of GFOGER to stimulate ty-
rosine phosphorylation when presented in suspension or
as a monolayer. Tyrosine phosphorylation was measured
by Western blotting using the anti-phosphotyrosine mAb
4G10. For the adhesion studies, unbound platelets were re-
moved by aspiration and adhered cells were solubilized using
Laemmli buffer. Unbound platelets that had been exposed
to a surface of BSA or GFOGER served as controls for these
studies. No significant difference was seen between the two
sets of controls (unpublished data). The protein concentra-
tion of each lysate was determined using an assay that mea-
sures protein levels in the presence of SDS so that equal lev-
els of protein could be added to each lane of the gel, making
an appropriate correction for the contribution of GFOGER. 
GFOGER stimulated a marked increase in tyrosine phos-
phorylation at 15 and 30 min when presented as a mono-
layer but not as a suspension (Fig. 5 A). The latter is in
agreement with a previous study (Knight et al., 1999). These
observations demonstrate a fundamental difference in the
behavior of adherent and suspended platelets upon exposure
to GFOGER. Tyrosine phosphorylation was dramatically
inhibited in the presence of PP2, although increases in a ma-
jor band of 60 kD and a more minor band of 125 kD were
observed at later times of stimulation (Fig. 5 A).
We sought to identify a number of the proteins that un-
dergo an increase in tyrosine phosphorylation in adherent
platelets through immunoprecipitation using specific antibod-
ies and reprobing for phosphotyrosine. P125
FAK is a nonrecep-
Figure 2. ADP stimulation promotes adhesion and spreading of 
FcR  -chain–deficient mouse platelets on collagen. (A, 1) Washed 
murine platelets (3   10
7/ml) from wild-type mice ( / ) were 
pretreated with the inhibitor cocktail and seeded on BSA- or 
collagen-coated coverslips and stained as described in Fig. 1. 
Photo images are representative of 5–10 different images from three 
experiments. (A, 2) The graph illustrates the mean number of adhered 
platelets   SEM per 0.028 mm
2 from seven different images from at 
least two separate experiments. (B, 1) Washed platelets (3   10
7/ml) 
from FcR  -chain ( / ) or ( / ) mice were pretreated with 100 
 M EGTA, 10  M indomethacin, and 10  M lotrafiban, with or 
without 10  g/ml anti–mouse integrin  2 antibody for 10 min. 
ADP (10  M) was present in parts i, iii, and iv. The ADP receptor 
antagonists A3P5P (1 mM) plus AR-C67085 (1  M) were present in 
part ii. Platelets were seeded on BSA- or collagen-coated coverslips 
and stained as described in Fig. 1. (B, 2) The mean number of 
adhered platelets   SEM per 0.028 mm
2 from 10 different images 
from three experiments is shown. One asterisk denotes P   0.05, 
and two asterisks denote P   0.01. The maximal diameter of between 
100 and 200 adhered platelets was measured. For adhered platelets 
on BSA-coated surfaces, diameters of 10 platelets were counted 
because of a lack of cells.T
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Figure 3. Spreading of human and mouse platelets on GFOGER peptide. (A, 1) Washed human platelets (2   10
7/ml) were pretreated 
with the inhibitor cocktail and then seeded on BSA- or GFOGER-coated coverslips in the presence or absence of 10  g/ml 6F1 and 
10  g/ml F(ab’)2 of IV.3. The platelets were fixed, stained, and photographed as described in Fig. 1. (A, 2) The mean number of adhered 
platelets   SEM per 0.028 mm
2 from between 10 and 20 images from six experiments was counted. (A, 3) Washed human platelets 
(2   10
7/ml) pretreated with the inhibitor cocktail were seeded on the GFOGER-coated glass plate for 30 min at 30 C. The picture was 
taken using phase contrast microscopy. (A, 4) Washed human platelets (2   10
7/ml) were pretreated with the inhibitor cocktail with or 
without 10  g/ml 6D1 plus 10  g/ml IV.3 or 10  g/ml mouse IgG1  plus 10  g/ml IV.3 and then seeded on the BSA- or GFOGER-coated 
coverslips, stained, and photographed as described in Fig. 1. (A, 5) Washed human platelets (3   10
8/ml) were pretreated with 100  M 
EGTA, 10  M indomethacin, 10  M lotrafiban, and 3 U/ml apyrase. 300  l of washed platelets was seeded on the dishes coated with 
1% BSA (C, control), 50  g/ml GFOGER, or 50  g/ml CRP for 30 min at 30 C. Platelets were dissolved by 150  l of 3  lysis buffer. 
Unbound platelets that had been exposed to a BSA-coated surface served as the zero time point. FcR  -chain was isolated by precipitation 
with GST–Syk SH2 fusion protein and blotted with 4G10 or anti–human FcR  -chain antibody. Results are representative of two experiments. 
(B) Washed platelets (3   10
7/ml) from wild-type mice, FcR  -chain ( / ) mice, and integrin  IIb ( / ) mice were pretreated with the 
inhibitor cocktail with or without 10  g/ml anti–mouse integrin  2 antibody for 10 min. Platelets were seeded on GFOGER-coated coverslips 
and stained as described in Fig. 1.T
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Figure 4. PP2 inhibits spreading, but not adhesion, mediated 
through integrin  2 1. (A, 1) Washed human platelets (2   10
7/ml) 
were pretreated with the inhibitor cocktail and 20  M PP2, 20  M 
PP3, or the equivalent volume of DMSO for 10 min before seeding 
on GFOGER-coated coverslips. The platelets were fixed, stained, 
and analyzed as described in Figs. 1 and 2. (A, 2) For the number of 
adhered platelets, data represent the mean number of adhered 
platelets   SEM per 0.028 mm
2 from 10 different images from three 
experiments. The mean diameter of between 150 and 400 platelets 
was measured. Two asterisks denote statistical significance of less 
than P   0.01. (B, 1) Washed platelets (3   10
7/ml) from FcR 
 -chain ( / ) mice were pretreated with 10  M ADP, 100  M 
EGTA, 10  M indomethacin, 10  M lotrafiban, and 20  M PP2 
or the equivalent volume of DMSO for 10 min before seeding on 
collagen-coated coverslips. (B, 2) For other conditions, see part A.
Figure 5. Integrin  2 1–mediated platelet spreading induces 
protein tyrosine phosphorylation. (A) Washed human platelets 
were pretreated with 100  M EGTA, 10  M indomethacin, 10  M 
lotrafiban, and 3 U/ml apyrase. Where indicated, 10  M ADP was 
added and apyrase omitted. Platelets were pretreated with 20  M 
PP2 as shown. For adhesion studies, 500  l washed platelets 
(4   10
8/ml) was seeded on the dishes coated with 1% BSA (C, control) 
or 50  g/ml GFOGER at 30 C for the indicated times. After removal 
of unbound platelets, adhered platelets were dissolved by 500  l 
Laemmli sample buffer. Unbound platelets that had been exposed 
to a BSA-coated surface served as the zero time point. For suspen-
sion studies, 500  l washed platelets (4   10
8/ml) in a glass cuvette 
was stimulated with 10  M ADP and then incubated with or without 
50  g/ml GFOGER for the indicated times with stirring at 30 C. 
After the protein concentrations of each sample were adjusted, 
proteins were separated by 8% SDS-PAGE, and protein tyrosine 
phosphorylation was blotted with 4G10. Results are representative 
of two separate experiments. (B) Washed human platelets (3   10
8/ml) 
were pretreated with the inhibitors and stimulated as described 
above. Reactions were stopped by the addition of an equal volume 
of 2  lysis buffer without removing unbound platelets. FAK (1) 
or PLC 2 (2) proteins were isolated by immunoprecipitation with 
anti-FAK pAb or anti-PLC 2 pAb and blotted with 4G10, anti-FAK 
mAb, or anti-PLC 2 pAb. Results are representative of three separate 
experiments. (C) Washed human platelets (3   10
8/ml) were pretreated 
with 100  M EGTA, 10  M indomethacin, 10  M lotrafiban, 
and 10  M ADP. 20  M PP2 was added as shown. Reactions 
were stopped, and FAK (1) or PLC 2 (2) proteins were isolated by 
immunoprecipitation as described above. Results are representative 
of three separate experiments.T
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tor tyrosine kinase that colocalizes with integrins at contact
sites with the subendothelium and undergoes an increase in
tyrosine phosphorylation on fibrinogen binding. Platelet ad-
hesion to the GFOGER monolayer leads to tyrosine phos-
phorylation of focal adhesion kinase (FAK) (Fig. 5 B). The in-
crease in tyrosine phosphorylation of FAK was substantially,
but not completely, inhibited in the presence of a concentra-
tion of PP2 (20  M) that causes complete inhibition of Src
kinase activity in platelets (Fig. 5 B). PLC 2 undergoes ty-
rosine phosphorylation in platelets exposed to a fibrinogen
surface downstream of the integrin  IIb 3 (Wonerow et al.,
2002). PLC 2 was also tyrosine phosphorylated in platelets
that had adhered to GFOGER (Fig. 5 B). Tyrosine phosphory-
lation of PLC 2 was completely inhibited by PP2 (20  M).
We sought to further investigate the PP2-independent ty-
rosine phosphorylation of FAK by GFOGER. It has been
previously shown that G protein–coupled receptor agonists
are able to potentiate integrin-dependent tyrosine phosphor-
ylation of FAK in platelets (Shattil et al., 1994). ADP poten-
tiated tyrosine phosphorylation of FAK by a GFOGER
monolayer in the presence of PP2, whereas it had no effect
on phosphorylation of PLC 2 (Fig. 5 C). Tyrosine phos-
phorylation of FAK by a GFOGER monolayer in the pres-
ence of ADP was maintained in the presence of a supra-
maximal concentration of PP2 (50  M; unpublished data).
On the other hand, tyrosine phosphorylation of FAK by
GFOGER was not observed in suspension studies in the
presence of ADP (Fig. 5 C).
These results demonstrate that adhesion to GFOGER
leads to tyrosine phosphorylation of FAK and PLC 2
through a Src kinase–dependent pathway. In addition, FAK
is partially regulated by a Src kinase–independent pathway
that is potentiated by ADP.
GFOGER peptide stimulates tyrosine phosphorylation 
of Src, Syk, SLP-76, and plasma membrane calcium 
ATPase (PMCA)
We sought to further characterize a number of the other ty-
rosine-phosphorylated proteins induced by the GFOGER
monolayer and, in particular, to compare these with the se-
quence of events mediated by the major platelet integrin
 IIb 3. Obergfell et al. (2002) has recently shown a key role
for Src in  IIb 3-dependent spreading. This is consistent
with the observation that PP2 and SU6656 partially inhibit
spreading and protein tyrosine phosphorylation induced by
GFOGER and suggests that the two integrins may signal in
a similar way. Obergfell et al. (2002) used a phosphospecific
antibody to Tyr-416 to demonstrate activation of Src during
spreading on fibrinogen. GFOGER stimulated a 1.5-fold in-
crease in phosphorylation on Tyr-416 at 5 and 10 min, the
earliest time points that could be investigated because of the
low number of adherent cells (Fig. 6 A). The smaller re-
sponse to GFOGER relative to that induced by adhesion to
fibrinogen (Obergfell et al., 2002) is likely to reflect the 50-
fold lower density of  2 1 relative to that of  IIb 3. Adhe-
sion to fibrinogen induces tyrosine phosphorylation of Syk
and SLP-76 but not the adaptor LAT, even though this is a
prominent phosphorylated band in GPVI-activated platelets
(Judd et al., 2000, 2002; Obergfell et al., 2001; Wonerow et
al., 2002). GFOGER also stimulated marked tyrosine phos-
phorylation of Syk and SLP-76, whereas tyrosine phosphor-
ylation of LAT was not detected (Fig. 6 B). Recently, it has
been reported that the plasma membrane calcium ATPase
(PMCA) on platelet membranes, which mediates calcium ef-
flux from the cytoplasm, is phosphorylated on tyrosine by
FAK and that this leads to its inhibition (Wan et al., 2003).
PMCA is also phosphorylated after adhesion to GFOGER
(Fig. 6 B, 4). These results demonstrate that activation of
Src is an early event in platelet adhesion to GFOGER and
that this is associated with tyrosine phosphorylation of Syk,
SLP-76, and PMCA, but not LAT, as well as FAK and
PLC 2, as described in the previous section.
GFOGER peptide stimulates spreading though PLC 2 
and mobilization of Ca
2 
The above results demonstrate two pathways that have the
potential to increase intracellular Ca
2  after adhesion to
GFOGER, namely via activation of PLC 2 downstream of
Src, Syk, and SLP-76 and through inhibition of PMCA by
Figure 6. Src Tyr-416, Syk, SLP-76, and PMCA are tyrosine 
phosphorylated during spreading on GFOGER. (A) 300  l of 
washed human platelets (3   10
8/ml) was pretreated with 100  M 
EGTA, 10  M indomethacin, 10  M lotrafiban, and 3 U/ml apyrase 
and seeded on the dishes coated with 1% BSA (C, control) or 
50  g/ml GFOGER at 30 C for the indicated times. Reactions 
were stopped by the addition of 150  l of 3  lysis buffer without 
removing unbound platelets. Src kinase was isolated by immuno-
precipitation with anti-Src mAb, separated by 8% SDS-PAGE, and 
immunoblotted with anti–Src tyrosine-416 (Y-416) pAb or anti-Src 
mAb. Phosphorylation of Src Y-416 was quantified using Quantity 
One software for Macintosh. Optical density was standardized by 
the recruitment of Src. The optical density measurements are shown 
above the corresponding lane. (B) 300  l washed human platelets 
(3   10
8/ml) was pretreated with the inhibitors and stimulated as 
described above. Reactions were stopped by the addition of 150  l 
of 3  lysis buffer without removing unbound platelets. Syk, 
SLP-76, LAT, and PMCA were isolated by immunoprecipitation and 
Western blotted as described in the Materials and methods. Results 
are representative of two experiments.T
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FAK, which is partially regulated by Src. Dynamic video im-
aging of Fura2-loaded platelets confirmed that GFOGER
stimulated an increase in Ca
2  in adherent cells (Fig. 7 A, 1).
A record from a representative cell shows that the increase in
Ca
2  consists of a series of oscillatory changes that decline
over time (Fig. 7 A, 2). The increase in Ca
2  was inhibited
completely in the presence of the intracellular Ca
2 –chelating
agent BAPTA-AM (Fig. 7 A, 1), which also reduced the num-
ber of adherent platelets and inhibited spreading (Fig. 7 B). In
contrast, chelation of extracellular Ca
2  with 1 mM EGTA
did not have a significant effect on adhesion or spreading
on GFOGER (unpublished data). PLC 2-deficient platelets
were used to investigate a possible causal link between tyrosine
phosphorylation of the lipase and spreading on GFOGER. A
similar number of wild-type and PLC 2-deficient platelets
formed stable adhesions on GFOGER, whereas spreading of
the lipase-deficient cells was significantly impaired (Fig. 8).
These results demonstrate that intracellular Ca
2  is essential
for  2 1-mediated platelet spreading and that this contributes
significantly to adhesion. The results also demonstrate a role
for PLC 2 in  2 1-mediated spreading.
Discussion
The present study provides evidence that activation of  2 1
induces spreading via a pathway that involves Src, Syk, SLP-
76, PLC 2, FAK, PMCA, and Ca
2  mobilization. This
pathway was not detectable in platelet suspensions, explain-
ing why previous studies have not reported signaling events
through the integrin in platelets. The observation that  2 1
signals only in response to immobilized ligand demonstrates
a unique mechanism to prevent platelet activation within
blood vessels and yet promote activation upon damage to
the subendothelial matrix. We speculate that  2 1-mediated
spreading may have particular relevance in strengthening at-
tachment of the thrombus to the subendothelial matrix
through processes such as clot retraction. Such a role would
account for the increased embolization of thrombi on col-
lagen that is seen with  1-deficient platelets (Kuijpers et al.,
2003). In addition, the observation that  2 1 and GPVI reg-
ulate a common set of proteins may enable the integrin to
compensate for the absence of the glycoprotein, at least to a
limited extent. This could explain the relatively small in-
crease in bleeding time in mice that are deficient in the
GPVI–FcR  -chain complex.
Suzuki-Inoue et al. (2001) originally described spreading
of human platelets on a surface coated with the F(ab’)2 frag-
ments of the anti–integrin  2 1 antibody TS2/16. More re-
cently, Guidetti et al. (2002) have provided evidence that
the small proteoglycan decorin induces tyrosine phosphory-
Figure 7. BAPTA-AM inhibits  2 1-mediated platelet adhesion 
and spreading on surfaces coated with GFOGER peptide. (A, 1) 
Washed human platelets (5   10
8/ml) were loaded with 10  M 
Fura2-AM for 1 h at 30 C and then washed and resuspended to 
2   10
7/ml in modified Tyrodes buffer with the inhibitor cocktail. 
2   10
6 platelets were added to a GFOGER-coated coverslip. 
Fluorescence imaging and Ca
2  concentration measurements were 
performed with fluorescent microscopy using Openlab software for 
Macintosh. Results are representative of three experiments. (A, 2) The 
calcium concentration in a single platelet is shown. (B, 1) Washed 
human platelets (2   10
7/ml) were pretreated with the inhibitor 
cocktail, with or without 10  M BAPTA-AM for 20 min. Platelets were 
seeded on BSA- or GFOGER-coated coverslips and stained and 
photographed as described in Fig. 1. (B, 2) The data represents the 
mean number of adhered platelets   SEM per 0.028 mm
2 from five 
different images from three experiments. The mean   SEM diameter 
of 200 platelets from three experiments was measured. **, P   0.01.T
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lation of Syk and PLC 2 in platelets through integrin  2 1.
In the present study, we have demonstrated spreading of
human and murine platelets on an  2 1-specific peptide,
GFOGER, that is unable to bind to GPVI or integrin
 IIb 3. Spreading on GFOGER is observed in the presence
of a cyclooxygenase inhibitor and antagonists at  IIb 3 and
ADP receptors, demonstrating a direct role for  2 1 in me-
diating platelet activation. We also observed spreading of
murine platelets deficient in GPVI–FcR  -chain on col-
lagen. These studies were performed in the presence of ADP
or PMA to induce activation of  2 1 and thereby promote
adhesion (Jung and Moroi, 1998, 2000).
Spreading on GFOGER is associated with a marked in-
crease in tyrosine phosphorylation of Src, Syk, SLP-76,
PLC 2, FAK, and PMCA and elevation of intracellular Ca
2 .
Tyrosine phosphorylation of PLC 2 is abolished in the pres-
ence of PP2 while phosphorylation of FAK is substantially in-
hibited. Spreading is reduced in the presence of Src kinase in-
hibitors and in PLC 2-deficient platelets and abolished by
chelation of intracellular Ca
2 . These observations demon-
strate that  2 1 mediates spreading through a Src kinase–
dependent pathway that lies upstream of PLC 2 and Ca
2 .
Syk and SLP-76 are likely to be downstream targets of Src by
analogy with the signaling events mediated by  IIb 3 (Judd et
al., 2000; Obergfell et al., 2001, 2002). The limited degree of
spreading observed in the presence of Src kinase inhibition
may be mediated through phosphorylation of PMCA by
FAK, leading to inhibition of Ca
2  extrusion (Wan et al.,
2003) and a slow elevation in the intracellular levels of the cat-
ion. A residual increase in Ca
2  mobilization (unpublished
data) is seen in the presence of PP2 on a GFOGER-coated
surface and is therefore consistent with this possibility. These
potential pathways are summarized in Fig. 9. 
It is important to consider why binding of FcR  -chain–
deficient platelets to GFOGER does not require prior activa-
tion of  2 1, whereas this is not the case for collagen. This
difference may be related to the frequency of the  2 1-specific
binding sequence, GFOGER, in collagen. There are only two
copies of GFOGER in a type I collagen molecule (a fre-
quency of 0.4%), although it does contain a number of other
GER-containing motifs that are likely to have a lower affinity
for the integrin. In contrast, GFOGER is present at a fre-
Figure 8. PLC 2-deficient murine platelets exhibit limited spreading 
on GFOGER peptide. (A) Washed platelets (3   10
7/ml) from PLC 2 
( / ) or ( / ) mice were pretreated with the inhibitor cocktail for 
10 min. Platelets were seeded on BSA- or GFOGER-coated coverslips 
and stained as described in Fig. 1. (B) The number and diameter of 
adhered platelets were measured as described in Fig. 2. The data 
represent the mean number of adhered platelets   SEM per
0.028 mm
2 from 10 different images from two experiments. The 
mean   SEM diameter of 200 platelets from two experiments was 
measured. **, P   0.01.
Figure 9. Model depicting the intracellular events during integrin 
 2 1–mediated platelet spreading. Integrin  2 1 mediates activation 
of a Src family kinase, Syk, and SLP-76 upstream of PLC 2, Ca
2  
mobilization, and platelet spreading. A second pathway can also 
give rise to Ca
2  mobilization and platelet spreading. This pathway 
may involve the tyrosine kinase FAK, whose phosphorylation is 
mediated, in part, through a Src kinase–independent pathway. 
A possible pathway of FAK-mediated increase in calcium is the 
inhibition of PMCA via tyrosine phosphorylation. T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
778 The Journal of Cell Biology | Volume 160, Number 5, 2003
quency of 14% in a GFOGER peptide (one copy per 42
amino acids). This frequency may be sufficient to ensure sta-
ble adhesion to the low-affinity (or inactive) form of  2 1
through a combination of affinity and avidity. Moreover,
once bound, the GFOGER peptide is likely able to convert
the integrin to its high-affinity (or active) conformation
through the generation of intracellular signals. On the other
hand, we consider it unlikely that binding to GFOGER pep-
tide can be explained by the presence of a significant popula-
tion of platelets that express  2 1 in its active conformation,
as adhesion of FcR  -chain–deficient platelets to collagen is
potentiated by stimuli that convert the integrin to a high-
affinity conformation. Further, an antibody (7F6) developed by
A. Schoolmeester and H. Deckmyn (Katholieke Universiteit
Leuven Campus Kortrijk, Kortrijk, Belgium) that recognizes
the active form of  2 1 demonstrated that the vast majority of
the integrin is in an inactive conformation (unpublished
data). It is also important to consider why platelets are acti-
vated by a monolayer of GFOGER peptide, whereas similar
results are not seen in suspension studies. The same question
applies to the interaction of platelets with fibrinogen. This is
most likely brought about through enhanced avidity caused
by movement of integrins to the exposed surface and potenti-
ation of intracellular signaling (Hato et al., 1998). 
It is of considerable interest that the mechanism of signal-
ing by  2 1 is similar to that of  IIb 3. Recently, Woodside
et al. (2002) have reported that the NH2-terminal SH2 do-
main and linker region of Syk bind with high affinity to the
tail of the  3 integrin subunit. In the same study, the authors
demonstrated that Syk binds with a slightly lower affinity to
the tail of the  1 integrin subunit. This gives rise to specula-
tion that the signaling pathways between the two integrin  
subunits are conserved, and that the sequence of events that
have been established for  IIb 3 may apply to other inte-
grins, including  2 1. Consistent with this, both integrins
are located outside of membrane rafts (Wonerow et al.,
2002), and both regulate Syk, SLP-76, FAK, and PLC 2,
but not the raft-associated adaptor LAT. 
The observation that  2 1 mediates spreading adds to the
growing list of platelet receptors that are able to mediate this
response, including GPVI,  IIb 3, and G protein–coupled re-
ceptor stimuli. This apparent redundancy brings into ques-
tion the significance of the present observations. Importantly,
however, the role of soluble mediators during thrombus
growth is compromised by their rapid removal in the flowing
blood and by recruitment of further platelets into the devel-
oping thrombus. In this context,  2 1 may play an important
role in the regulation of spreading, especially bearing in mind
the high collagen content of the subendothelial matrix.
Additional work is required to establish the physiological
and pathological significance of the  2 1-dependent signals
reported in the present study. Although mice deficient in
 2 1 do not exhibit a marked increase in tail bleeding times
(Nieswandt et al., 2001a; Holtkötter et al., 2002), the inte-
grin may play an important role in vascular beds that are
high in collagen or that have a different type of lesion. In
this context, the observation of increased embolization of
 1-deficient thrombi is of particular interest (Kuijpers et al.,
2003). The significance of  2 1-dependent signals may also
be masked in the presence of GPVI. Indeed, the converse
may also apply in that the relatively small increase in bleed-
ing times observed in GPVI-deficient platelets (Nieswandt
et al., 2001b) may be due to  2 1-mediated intracellular sig-
nals. Strikingly, the two receptors regulate a common set
of proteins, including Src kinases and PLC 2. Signaling
through  2 1 may also have a significant role in pathological
thrombosis, and this could explain the increase in throm-
botic risk that is seen in individuals with polymorphisms
that lead to an increase in expression of the integrin  2 1
(Kunicki, 2002). Agents that prevent signaling by  2 1
therefore represent potential novel anti-thrombotics. PLC 2
also appears to be a particularly good target in that it lies
downstream of the integrins  2 1 and  IIb 3, as well as the
major receptor for collagen, GPVI.
Materials and methods
Materials
Anti–integrin  2 mAb 6F1 and anti–glycoprotein Ib mAb 6D1 were gifts from
B. Coller (Mt. Sinai Medical Center, New York, NY). Anti–SLP-76 pAb was
donated by G. Koretzky (University of Pennsylvania, Philadelphia, PA).
The anti-PMCA pAb was raised as previously described (Blankenship et
al., 2000). 2-propylthio-d-fluoromethylene adenosine 5-trisphosphate (AR-
C67085) was a gift from AstraZeneca. FcR  -chain– (Snell et al., 2002),
PLC 2- (Wang et al., 2000), and  IIb-deficient mice (provided by J. Frampton
and N.R. Emambokus, University of Birmingham) were bred on a B6 back-
ground. Mice were genotyped by PCR and wild-type litter mates used as con-
trols. GFOGER peptide(GPC[GPP]5GFOGER[GPP]5GPC) was synthesized
by TANA laboratories and cross-linked using N-succinimidyl 3-[2-pyri-
dyldithio]propionate (SPDP) (Morton et al., 1995). 4-amino-5-(4-chlorophe-
nyl)-7-(t-butil)pyrazolo[3,4-d]pyrimidine (PP2) and 4-amino-7-phenylpyra-
zolo[3,4-d]pyrimidine (PP3) were from Calbiochem. SU6656 was from
SUGEN. Anti-phosphotyrosine mAb (4G10), anti–FcR  -subunit pAb for
Western blotting, anti-Src mAb (GD11), and anti-LAT pAb were from Upstate
Biotechnology. Purified anti–mouse  2 integrin mAb (HM 2), hamster IgG1 
(A19-3), anti–SLP-76 mAb, and anti-FAK mAb (clone 8) for Western blotting
were from Becton Dickinson. Hybridoma of anti–human FcR  RIIA (IV.3)
was obtained from American Type Culture Collection, and F(ab’)2 fragment
of IV.3 was generated using ImmunoPure
® F(ab’)2 preparation kit. Anti-FAK
pAb (C-903) and anti-Syk pAb (LR) for immunoprecipitation and anti-Syk
mAb (4D10) for Western blotting were from Santa Cruz Biotechnology, Inc.
An anti-PMCA mAb for Western blotting (5F10), mouse IgG1  (MOPC 21),
ADP, adenosine 3-phosphate 5-phosphate (A3P5P), and TRITC-conjugated
phalloidin were from Sigma-Aldrich. Anti–phospho-Src family (Tyr416) pAb
was from New England Biolabs, Inc. Fura2-AM was from Molecular Probes.
RC DC protein assay kit II was from Bio-Rad Laboratories. All other reagents
were from previously named sources (Wonerow et al., 2002). 
Preparation of human and murine platelets
Venous blood from healthy drug-free volunteers was taken into 10% so-
dium citrate. Platelet-rich plasma was obtained after centrifugation at 200
g for 20 min with 15% acid–citrate–dextrose. EGTA (1 mM) was added,
and the platelet-rich plasma was centrifuged at 640 g for 15 min. Murine
blood was drawn from CO2 terminally anesthetized mice by cardiac punc-
ture and taken into 100  l of acid–citrate–dextrose, and washed platelets
were prepared as previously described (Snell et al., 2002). Human and
murine platelets were resuspended in modified Tyrodes buffer (137 mM
NaCl, 11.9 mM NaHCO3, 0.4 mM Na2HPO4, 2.7 mM KCl, 1.1 mM MgCl2,
5.6 mM glucose, pH 7.3) at a cell density of 0.2–4   10
8/ml. Platelet sus-
pensions were left for 30 min and then incubated with 10  M lotrafiban,
10  M indomethacin, 100  M EGTA, and, where necessary, 1 mM A3P5P
and 1  M AR-C67085 for 10 min before experimentation. The concentra-
tion of DMSO in the incubation never exceeded 0.2%, and an equivalent
volume of DMSO was present in controls.
Platelet spreading
For the spreading experiments, 50  g/ml collagen or 50  g/ml cross-linked
GFOGER peptide was incubated on a coverslip overnight at 4 C. After
washing twice with PBS, the coverslip was blocked with 1% fatty acid–free
purified BSA in PBS for 2 h at room temperature and washed twice with
modified Tyrodes. Washed murine platelets (3   10
7/ml) and washed hu-T
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man platelets (2   10
7/ml) were incubated on the coverslips at 30 C. After
removal of unbound platelets by washing with modified Tyrodes buffer,
adhered platelets were fixed, permeabilized, and stained by TRITC-conju-
gated phalloidin, as described previously (Suzuki-Inoue et al., 2001).
Platelets were viewed on an inverted fluorescent microscope (Carl Zeiss
MicroImaging, Inc.), and digital imaging ( 400) was performed using
Openlab software for Macintosh. The number and diameter of platelets
were counted and measured by a ruler on the printed images (0.028 mm
2/
image). Statistical significance was evaluated by the t test using a software
for statistics, T-Kentakun. In each case, P   0.05 was taken as the mini-
mum value to indicate statistical significance.
For phase contrast imaging, glass plates were incubated with 50  g/ml
of cross-linked GFOGER peptide overnight. The plates were then blocked
with 1% BSA as described above. Platelets were viewed on a phase con-
trast microscope (Carl Zeiss MicroImaging, Inc.), and digital imaging
( 600) was performed using LaserSharp 2000 software.
Protein precipitation studies
Six-well flat-bottomed plates were coated with cross-linked GFOGER pep-
tide (50  g/ml) overnight at 4 C. The plates were washed and blocked, as
described above, before incubation with 500  l washed platelets (4   10
8/
ml) at 30 C for 15–30 min. Unbound platelets were removed by aspiration,
and adhered cells were solubilized with 500  l Laemmli sample buffer. A
sample of the suspension was taken at the same time and used as a con-
trol. Protein concentrations were determined by RC DC protein assay kit II
according to the manufacturer’s instruction, and matched amounts of pro-
tein were separated by one-dimensional SDS-PAGE. Protein tyrosine phos-
phorylation was measured by Western blotting with 4G10. Protein loading
was measured by Coomassie brilliant blue staining.
Immunoprecipitation studies were performed as previously described
(Suzuki-Inoue et al., 2002). 500  l of 2  ice-cold lysis buffer (2% vol/vol
Nonidet P-40, 20 mM Tris, 300 mM NaCl, 2 mM EDTA, 2 mM EGTA, 1
mM phenylmethylsulfonyl fluoride, 2 mM Na3VO4, 10  g/ml leupeptin,
10  g/ml aprotinin, 1  g/ml pepstatin A, pH 7.3) was added to each well
without removing unbound platelets. After removing debris and preclear-
ing, the supernatants were incubated with 6  l anti-FAK pAb, 2  l anti-
PLC 2 pAb, 2  l anti-Src mAb, 2  l anti-Syk pAb, 2  l anti–SLP-76 pAb, 4
 l anti-LAT pAb, or 20  l anti-PMCA pAb and 30  l protein A–Sepharose
at 4 C overnight. FcR  -chain was precipitated using glutathione-agarose
conjugated with GST–Syk SH2 as previously described (Gibbins et al.,
1996). After centrifugation, the pellet was washed and then solubilized by
addition of 2  Laemmli sample buffer, and proteins were separated by
SDS-PAGE on 8% gels. Protein tyrosine phosphorylation was detected
by blotting with 4G10 or anti–Src Tyr416 pAb. Gels were reprobed with
anti-FAK mAb, anti-PLC 2 pAb, anti-Src mAb, anti-Syk mAb, anti–SLP-76
mAb, anti-LAT pAb, or anti-PMCA mAb. Phosphorylation of Src Tyr416
was quantified using Quantity One software for Macintosh.
Intracellular Ca
2  measurement
Platelet suspensions (5   10
8/ml) were loaded with 10  M Fura2-AM at
30 C for 1 h. Platelets were washed and resuspended to 2   10
7/ml in
modified Tyrodes buffer with 1 mM EGTA, 10  M indomethacin, 10  M
lotrafiban, 1 mM A3P5P, and 1  M AR-C67085. 2   10
6 platelets were
added to a GFOGER-coated coverslip, and fluorescence imaging was per-
formed using Openlab software for Macintosh as described previously
(Mountford et al., 1999).
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